Richard Small

Biography

Mr. Small joined Neurotech as Vice President and CFO in July, 2007 and was promoted to COO/CFO in March, 2016. He has 25 years of both private and public life sciences experience and more than 35 years of overall financial and operational management. He also currently serves as a Trustee, Executive Committee Member and Chairman of the Finance and Business Affairs Committee for the New England College of Optometry. Previously Mr. Small served as Senior Vice President and Chief Financial Officer of Point Therapeutics, a publicly-traded biotechnology company, where he was involved in taking the company public through a reverse merger and in raising in excess of $100 million. Prior to that he served as Vice President, Chief Financial Officer at Immulogic Pharmaceutical, Inc., a publicly-traded biotechnology company, where he was involved in multiple licensing deals and several public offerings. His early career was spent in senior management positions at Dennison Manufacturing Company and he began his career at the public accounting firm of Coopers and Lybrand, LLC. Mr. Small is a certified public accountant and has a BS in accounting from Northeastern University in Boston, Massachusetts.

Research Interest

Accounting